Citation tools

MOSER, SARAH SHARMAN et al "Time on Treatment and Survival Outcomes for Patients Treated With First-line Osimertinib vs. Other Tyrosine Kinase Inhibitors, for EGFR Mutation-positive Metastatic Non-small Cell Lung Cancer: Real-world Experience Data." Anticancer Research 44.1 (2024): 257-265. Web. 18 Nov. 2025.

Citation Manager Formats